X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DR. REDDYS LAB ALKEM LABORATORIES/
DR. REDDYS LAB
 
P/E (TTM) x - 27.6 - View Chart
P/BV x 6.2 2.8 218.2% View Chart
Dividend Yield % 0.7 1.0 70.1%  

Financials

 ALKEM LABORATORIES   DR. REDDYS LAB
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
DR. REDDYS LAB
Mar-16
ALKEM LABORATORIES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,5894,383 36.3%   
Low Rs1,2322,750 44.8%   
Sales per share (Unadj.) Rs417.5920.1 45.4%  
Earnings per share (Unadj.) Rs56.3126.1 44.6%  
Cash flow per share (Unadj.) Rs64.7183.0 35.4%  
Dividends per share (Unadj.) Rs12.7020.00 63.5%  
Dividend yield (eoy) %0.90.6 160.6%  
Book value per share (Unadj.) Rs292.9685.8 42.7%  
Shares outstanding (eoy) m119.57170.61 70.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.43.9 87.2%   
Avg P/E ratio x25.128.3 88.6%  
P/CF ratio (eoy) x21.819.5 111.8%  
Price / Book Value ratio x4.85.2 92.6%  
Dividend payout %22.615.9 142.2%   
Avg Mkt Cap Rs m168,653608,481 27.7%   
No. of employees `000NA21.7 0.0%   
Total wages/salary Rs m9,17131,874 28.8%   
Avg. sales/employee Rs ThNM7,244.4-  
Avg. wages/employee Rs ThNM1,470.9-  
Avg. net profit/employee Rs ThNM992.8-  
INCOME DATA
Net Sales Rs m49,915156,978 31.8%  
Other income Rs m1,6452,693 61.1%   
Total revenues Rs m51,561159,671 32.3%   
Gross profit Rs m8,48234,587 24.5%  
Depreciation Rs m1,0069,705 10.4%   
Interest Rs m671824 81.4%   
Profit before tax Rs m8,45126,751 31.6%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6065,237 30.7%   
Profit after tax Rs m6,73121,514 31.3%  
Gross profit margin %17.022.0 77.1%  
Effective tax rate %19.019.6 97.1%   
Net profit margin %13.513.7 98.4%  
BALANCE SHEET DATA
Current assets Rs m27,062118,201 22.9%   
Current liabilities Rs m15,32468,368 22.4%   
Net working cap to sales %23.531.7 74.1%  
Current ratio x1.81.7 102.1%  
Inventory Days Days6760 110.9%  
Debtors Days Days4197 42.6%  
Net fixed assets Rs m12,61072,265 17.4%   
Share capital Rs m239853 28.0%   
"Free" reserves Rs m34,490111,548 30.9%   
Net worth Rs m35,027117,009 29.9%   
Long term debt Rs m1,21210,690 11.3%   
Total assets Rs m54,387200,104 27.2%  
Interest coverage x13.633.5 40.6%   
Debt to equity ratio x00.1 37.9%  
Sales to assets ratio x0.90.8 117.0%   
Return on assets %13.611.2 121.9%  
Return on equity %19.218.4 104.5%  
Return on capital %24.921.6 115.1%  
Exports to sales %12.946.3 28.0%   
Imports to sales %3.19.0 34.5%   
Exports (fob) Rs m6,46172,618 8.9%   
Imports (cif) Rs m1,54014,050 11.0%   
Fx inflow Rs m6,56375,405 8.7%   
Fx outflow Rs m3,01227,115 11.1%   
Net fx Rs m3,55248,290 7.4%   
CASH FLOW
From Operations Rs m7,25940,476 17.9%  
From Investments Rs m1,864-19,421 -9.6%  
From Financial Activity Rs m-9,273-17,009 54.5%  
Net Cashflow Rs m-1504,046 -3.7%  

Share Holding

Indian Promoters % 66.9 25.5 262.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 5.4 613.0%  
FIIs % 0.0 35.3 -  
ADR/GDR % 0.0 18.5 -  
Free float % 0.0 15.3 -  
Shareholders   68,381 75,885 90.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  AUROBINDO PHARMA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Amid Fed and ECB Minutes, L&T, Power Grid & IOC Among Other Top Stocks to Watch Out Today(Pre-Open)

On Thursday, Indian share markets oscillated between green and red in a broad range throughout the day and ended the session with marginal gains, with Nifty holding 9,900 mark.

Related Views on News

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS